Trimethoprim-sulfamethoxazole induced circulatory shock in a human immunodeficiency virus uninfected patient: A case report and review

Patricia Liu, Gregory P. Ranches, Jeffrey A. Gold

Research output: Contribution to journalArticle

Abstract

Background: Severe systemic reactions resembling septic shock have been described following trimethoprim-sulfamethoxazole (TMP-SMX) administration. Nearly all cases described in the literature occurred in HIV-infected patients. Case presentation: We present a 42-year-old woman with a history of systemic lupus erythematosus (SLE) who was admitted to the Intensive Care Unit (ICU) twice with fever and circulatory shock after taking a dose of TMP-SMX 800-160 mg. She had no respiratory distress, urticarial rash or eosinophilia on presentation. Infectious workup during both admissions was negative and treatment with antibiotics, steroids and vasopressors was de-escalated with clinical improvement. She was found to be HIV negative, however, labs revealed a low CD4+ count. Conclusions: TMP-SMX can rarely result in a severe, non-anaphylactic circulatory shock; if initially unrecognized, patients may undergo repeat drug exposure with an associated high morbidity risk. While more commonly reported in HIV individuals, this case demonstrates that TMP-SMX related circulatory shock can occur in a HIV negative patient.

Original languageEnglish (US)
Article number76
JournalBMC pharmacology & toxicology
Volume19
Issue number1
DOIs
StatePublished - Nov 20 2018

Keywords

  • Adverse drug reaction
  • CD4+ count
  • HIV
  • IL-6
  • Shock
  • Trimethoprim-sulfamethoxazole

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Trimethoprim-sulfamethoxazole induced circulatory shock in a human immunodeficiency virus uninfected patient: A case report and review'. Together they form a unique fingerprint.

  • Cite this